Clinical Trial Update: Effect of Genetic Polymorphism on the Clinical Outcome to SGLT2 Inhibitors in Heart Failure Patients

View source ↗

Summary

This clinical trial update describes a study investigating whether genetic polymorphisms influence outcomes to SGLT2 inhibitors in patients with heart failure, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Fibrosis
• Cardiac Remodeling
• Heart Failure

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Ain Shams University | Conditions: Heart Failure - NYHA II - IV, Cardiac Fibrosis | Status: ACTIVE_NOT_RECRUITING